Dermatologic Manifestations of Neurofibromatosis Type 1 and Emerging Treatments

11Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

Abstract

Neurofibromatosis type 1 (NF1) is an autosomal dominant tumor predisposition syndrome that increases one’s risk for both benign and malignant tumors. NF1 affects every organ in the body, but the most distinctive symptoms that are often the most bothersome to patients are the cutaneous manifestations, which can be unsightly, cause pain or pruritus, and have limited therapeutic options. In an effort to increase awareness of lesser-known dermatologic associations and to promote multidisciplinary care, we conducted a narrative review to shed light on dermatologic associations of NF1 as well as emerging treatment options. Topics covered include cutaneous neurofibromas, plexiform neurofibromas, diffuse neurofibromas, distinct nodular lesions, malignant peripheral nerve sheath tumors, glomus tumors, juvenile xanthogranulomas, skin cancer, and cutaneous T-cell lymphoma.

Cite

CITATION STYLE

APA

Poplausky, D., Young, J. N., Tai, H., Rivera-Oyola, R., Gulati, N., & Brown, R. M. (2023, May 1). Dermatologic Manifestations of Neurofibromatosis Type 1 and Emerging Treatments. Cancers. MDPI. https://doi.org/10.3390/cancers15102770

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free